Kazuyuki Nakagome

President of the National Center of Neurology and Psychiatry

Appears in 1 story

Stories

Brogidirsen shows 5-year motor function stability in Duchenne muscular dystrophy trial

Leads the institute that co-discovered brogidirsen and ran the first-in-human trial

Six boys with Duchenne muscular dystrophy have taken weekly doses of brogidirsen for five years. New data presented at the World Muscle Society congress in Hiroshima shows their motor function held steady and no serious side effects appeared.

Updated 2 hours ago